Myasthenia Gravis Disease Treatment Market Benefits from Rising Investments in Rare Disease Therapies
The treatment landscape for myasthenia gravis is undergoing a profound transformation as advanced biologics and targeted therapies gain prominence across global healthcare systems. Myasthenia gravis is a chronic autoimmune disorder characterized by impaired neuromuscular transmission, leading to fluctuating muscle weakness and fatigue. While conventional therapies remain important,...
0 Comments 0 Shares 277 Views 0 Reviews